4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-22-000005
Director acquired 1,265 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dubin Glenn Director | 2022-10-03 | Grant or award | +1,265 | $8.69 | $10,993 | 3,510 | D |
Loading xslF345X03/wf-form4_166492113147782.xml…